Exhibit 10.1


 


NOTE
PURCHASE AGREEMENT


 


THIS
NOTE PURCHASE AGREEMENT (this “Agreement”) is dated as of June 22, 2016 (the “Agreement Date”),
by and between OMAGINE, INC., a corporation organized and existing under the laws of the State of Delaware (the “Company”),
and YA II PN, LTD, a Cayman Islands exempt limited liability company (the “Investor”).


 


WITNESSETH


 


WHEREAS,
the parties desire that, upon the terms and subject to the conditions contained herein, the Company may issue and sell to the
Investor, as provided herein, and the Investor shall purchase a note substantially in the form attached hereto as Exhibit A
(the “Note”) in an aggregate principal amount of $400,000;


 


NOW,
THEREFORE, in consideration of the mutual covenants and other agreements contained in this Agreement the Company and the Investor
hereby agree as follows:


 


1.     PURCHASE
AND SALE OF NOTE;


 


(a)      Purchase
of Note. On the first business day following the satisfaction of all of the conditions precedent set forth below (the “Closing
Date”), the Company shall sell, and the Investor shall purchase, a Note in the principal amount of $400,000 on the terms
and conditions and in reliance on the Company’s representations and warranties, all as set forth herein. The Note shall
be in the form attached hereto as Exhibit A.


 


(b)      Form
of Payment. Subject to the satisfaction of the terms and conditions of this Agreement, on the Closing Date, (i) the Investor
shall deliver to the Company the principal amount of the Note to be issued and sold to the Investor; provided, however,
that the Investor shall deduct a commitment fee in the amount of $40,000.00 from the proceeds of the Note (to be payable to YA
Global II SPV LLC as designee of the Investor) and any other deductions of payments to be made on behalf of the Company as agreed
upon between the parties and set out on a signed closing statement (the “Closing Statement”), and (ii) the
Company shall deliver to the Investor, the Note duly executed on behalf of the Company.


 


(c)      Conditions
Precedent. The obligation of the Investor hereunder to purchase the Note pursuant hereto is subject to the satisfaction, at
or before the Closing Date, of each of the following conditions, provided that these conditions are for the Investor’s sole
benefit and may be waived by the Investor at any time in its sole discretion:


 


(i)      There
shall not have been any condition, circumstance, or situation that has resulted in or would reasonably be expected to result in
a “Material Adverse Effect,” where “Material Adverse Effect” shall mean any condition, circumstance, or
situation that may result in, or reasonably be expected to result in (1) a material adverse effect on the legality, validity or
enforceability of this Agreement or the transactions contemplated herein, (2) a material adverse effect on the results of operations,
assets, business or condition (financial or otherwise) of the Company, taken as a whole, or (3) a material adverse effect on the
Company’s ability to perform in any material respect on a timely basis its obligations under this Agreement;


 


(ii)     The
Company’s common stock (“Common Stock”) shall be authorized for quotation or trading on the NASDAQ Stock
Market, the NYSE Euronext, the New York Stock Exchange, or the OTCQX, OTCQB, or OTC Pink marketplaces of the OTC Markets Group,
whichever is at the time the principal trading exchange or market for the Common Stock (the “Principal Market”)
and trading in the Common Stock shall not have been suspended for any reason;


 






     


     


    

 


(iii)    The
Company is not in material default nor aware of any potential material default with any of its lenders, except as has been disclosed
in the Company’s filings with the United States Securities and Exchange Commission (the “SEC”);


 


(iv)    The
Company has received all necessary authorizations to sell the Note to the Investor; and


 


(v)     The
parties have signed a Closing Statement in an agreed upon form.


 


(d)      In
the event that the Closing Date has not occurred by July 22, 2016, the Investor may terminate this Agreement.


  


2.     INVESTOR’S
REPRESENTATIONS AND WARRANTIES.


 


Investor
hereby represents and warrants to the Company that the following are true and correct as of the date hereof, and as of the Closing
Date:


 


(a)      Organization
and Authorization. The Investor is duly organized, validly existing and in good standing under the laws of the Cayman Islands
and has all requisite power and authority to purchase and hold the Note. The decision to invest and the execution and delivery
of this Agreement by such Investor, the performance by such Investor of its obligations hereunder and the consummation by such
Investor of the transactions contemplated hereby have been duly authorized and requires no other proceedings on the part of the
Investor. The undersigned has the right, power and authority to execute and deliver this Agreement and all other instruments on
behalf of the Investor. This Agreement has been duly executed and delivered by the Investor and, assuming the execution and delivery
hereof and acceptance thereof by the Company, will constitute the legal, valid and binding obligations of the Investor, enforceable
against the Investor in accordance with its terms.


 


(b)      Evaluation
of Risks. The Investor has such knowledge and experience in financial, tax and business matters as to be capable of evaluating
the merits and risks of, and bearing the economic risks entailed by, an investment in the Company and of protecting its interests
in connection with this transaction. It recognizes that its investment in the Company involves a high degree of risk.


 


(c)      Investment
Purpose. The Note is purchased by the Investor for its own account, and for investment purposes. The Investor agrees not to
assign or in any way transfer the Investor’s rights to the Note or any interest therein and acknowledges that the Company
will not recognize any purported assignment or transfer of the Note except in accordance with applicable Federal and state securities
laws. No other person has or will have a direct or indirect beneficial interest in the Note. The Investor agrees not to sell,
hypothecate or otherwise transfer the Note unless the Note is registered under Federal and applicable state securities laws or
unless, in the opinion of counsel satisfactory to the Company, an exemption from such laws is available.


 






    	 	2	 



     

    

 


(d)      Accredited
Investor. The Investor is an “Accredited Investor” as that term is defined in Rule 501(a)(3) of Regulation
D of the Securities Act of 1933 (the “Securities Act”).


 


(e)      Information.
The Investor and its advisors (and its counsel), if any, have been furnished with all materials relating to the business, finances
and operations of the Company and information it deemed material to making an informed investment decision. The Investor and its
advisors, if any, have been afforded the opportunity to ask questions of the Company and its management. Neither such inquiries
nor any other due diligence investigations conducted by such Investor or its advisors, if any, or its representatives shall modify,
amend or affect the Investor’s right to rely on the Company’s representations and warranties contained in this Agreement.
The Investor understands that its investment involves a high degree of risk. The Investor has sought such accounting, legal and
tax advice, as it has considered necessary to make an informed investment decision with respect to this transaction.


 


(f)      No
General Solicitation. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has engaged
in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection
with the offer or sale of the Note offered hereby.


 


(g)      Not
an Affiliate. The Investor is not an officer, director or a person that directly, or indirectly through one or more intermediaries,
controls or is controlled by, or is under common control with the Company or any “Affiliate” of the Company
(as that term is defined in Rule 405 of the Securities Act).


  


3.    COMPANY’S
REPRESENTATIONS AND WARRANTIES. Except as stated below or in the SEC Documents (as defined below), the Company hereby represents
and warrants to, the Investor that the following are true and correct as of the date hereof, and as of the Closing Date:


 


(a)      Organization
and Qualification. The Company is duly incorporated, validly existing and in good standing under the laws of the State of
Delaware and has all requisite corporate power to own its properties and to carry on its business as now being conducted. Each
of the Company and its subsidiaries is duly qualified as a foreign corporation to do business and is in good standing in every
jurisdiction in which the nature of the business conducted by it makes such qualification necessary, except to the extent that
the failure to be so qualified or be in good standing would not have a Material Adverse Effect on the Company and its subsidiaries
taken as a whole. The Company has furnished or made available to the Investor true and correct copies of the Company’s Re-Stated
Certificate of Incorporation as in effect on the date hereof (the “Certificate of Incorporation”), and the
Company’s By-laws, as in effect on the date hereof (the “By-laws”), and the terms of all securities convertible
into or exercisable for Common Stock and the material rights of the holders thereof in respect thereto.


 






    	 	3	 



     

    

 


(b)      Authorization,
Enforcement, Compliance with Other Instruments. (i) The Company has the requisite corporate power and authority to enter into
and perform this Agreement and any related agreements, in accordance with the terms hereof and thereof, (ii) the execution and
delivery of this Agreement and any related agreements by the Company and the consummation by it of the transactions contemplated
hereby and thereby, have been duly authorized by the Company’s Board of Directors and no further consent or authorization
is required by the Company, its Board of Directors or its stockholders, (iii) this Agreement, the Note (when issued) and
any related agreements have been duly executed and delivered by the Company, (iv) this Agreement, the Note (when issued), and
any related agreements, constitute the valid and binding obligations of the Company enforceable against the Company in accordance
with their terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of creditors’
rights and remedies.


 


(c)      No
Conflict. The execution, delivery and performance of this Agreement by the Company and the consummation by the Company of
the transactions contemplated hereby will not (i) result in a violation of the Certificate of Incorporation, any certificate of
designations of any outstanding series of preferred stock of the Company or By-laws or (ii) conflict with or constitute a default
(or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or any of its subsidiaries
is a party, or result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities
laws and regulations and the rules and regulations of the Principal Market on which the Common Stock is quoted) applicable to
the Company or any of its subsidiaries or by which any material property or asset of the Company or any of its subsidiaries is
bound or affected and which would cause a Material Adverse Effect. Except as disclosed in the SEC Documents (as defined below),
neither the Company nor its subsidiaries is in violation of any term of or in default under its Articles of Incorporation or By-laws
or their organizational charter or by-laws, respectively, or any material contract, agreement, mortgage, indebtedness, indenture,
instrument, judgment, decree or order or any statute, rule or regulation applicable to the Company or its subsidiaries. The business
of the Company and its subsidiaries is not being conducted in violation of any material law, ordinance, regulation of any governmental
entity. Except as specifically contemplated by this Agreement and as required under the Securities Act and any applicable state
securities laws, the Company is not required to obtain any consent, authorization or order of, or make any filing or registration
with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under or contemplated
by this Agreement in accordance with the terms hereof or thereof except as such consent, authorization or order has been obtained
prior to the date hereof. The Company and its subsidiaries are unaware of any fact or circumstance which might give rise to any
of the foregoing.


 






    	 	4	 



     

    

 


(d)      SEC
Documents; Financial Statements. The Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of
1934 (the “Exchange Act”) and the Company has filed all reports, schedules, forms, statements and other documents
required to be filed by it with the SEC under the Exchange Act for the two years preceding the date hereof (or such shorter period
as the Company was required by law or regulation to file such material) (all of the foregoing filed within the two years preceding
the date hereof as amended after the date hereof and all exhibits included therein and financial statements and schedules thereto
and documents incorporated by reference therein, being hereinafter referred to as the “SEC Documents”) on a
timely basis or has received a valid extension of such time of filing and has filed any such SEC Document prior to the expiration
of any such extension. The Company has delivered to the Investor or its representatives, or made available through the SEC’s
website at http://www.sec.gov, true and complete copies of the SEC Documents. As of their respective dates, the SEC Documents
complied in all material respects with the requirements of the Exchange Act and the rules and regulations of the SEC promulgated
thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading. As of their respective
dates, the financial statements of the Company included in the SEC Documents complied as to form in all material respects with
applicable accounting requirements and the published rules and regulations of the SEC with respect thereto. Such financial statements
have been prepared in accordance with generally accepted accounting principles, consistently applied, during the periods involved
(except (i) as may be otherwise indicated in such financial statements or the notes thereto, or (ii) in the case of unaudited
interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present in
all material respects the financial position of the Company as of the dates thereof and the results of its operations and cash
flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments). No other
information provided by or on behalf of the Company to the Investor which is not included in the SEC Documents contains any untrue
statement of a material fact or omits to state any material fact necessary in order to make the statements therein, in the light
of the circumstance under which they are or were made, not misleading.


 


(e)      No
Default. Except as disclosed in the SEC Documents, the Company is not in default in the performance or observance of any material
obligation, agreement, covenant or condition contained in any indenture, mortgage, deed of trust or other material instrument
or agreement to which it is a party or by which it or its property is bound and neither the execution, nor the delivery by the
Company, nor the performance by the Company of its obligations under this Agreement or any of the exhibits or attachments hereto
will conflict with or result in the breach or violation of any of the terms or provisions of, or constitute a default or result
in the creation or imposition of any lien or charge on any assets or properties of the Company under its Certificate of Incorporation,
By-Laws, any material indenture, mortgage, deed of trust or other material agreement applicable to the Company or instrument to
which the Company is a party or by which it is bound, or any statute, or any decree, judgment, order, rule or regulation of any
court or governmental agency or body having jurisdiction over the Company or its properties, in each case which default, lien
or charge is likely to cause a Material Adverse Effect.


 


(f)      Internal
Accounting Controls. The Company and each of its subsidiaries maintain a system of internal accounting controls sufficient
to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted
accounting principles and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s
general or specific authorization and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences.


 






    	 	5	 



     

    

 


(g)      Absence
of Litigation. Except as set forth in the SEC Documents, there is no action, suit, proceeding, inquiry or investigation before
or by any court, public board, government agency, self-regulatory organization or body pending against or affecting the Company,
the Common Stock or any of the Company’s subsidiaries, wherein an unfavorable decision, ruling or finding would have a Material
Adverse Effect.


 


(h)      Subsidiaries.
Except as disclosed in the SEC Documents, the Company does not presently own or control, directly or indirectly, any interest
in any other corporation, partnership, association or other business entity.


 


(i)      Tax
Status. Except as disclosed in the SEC Documents, the Company and each of its subsidiaries has made or filed all federal and
state income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject and (unless
and only to the extent that the Company and each of its subsidiaries has set aside on its books provisions reasonably adequate
for the payment of all unpaid and unreported taxes) has paid all taxes and other governmental assessments and charges that are
material in amount, shown or determined to be due on such returns, reports and declarations, except those being contested in good
faith and has set aside on its books provision reasonably adequate for the payment of all taxes for periods subsequent to the
periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due
by the taxing authority of any jurisdiction, and the officers of the Company know of no basis for any such claim.


 


(j)      Certain
Transactions. Except as set forth in the SEC Documents none of the officers, directors, or employees of the Company is presently
a party to any transaction with the Company (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property
to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company,
any corporation, partnership, trust or other entity in which any officer, director, or any such employee has a substantial interest
or is an officer, director, trustee or partner.


 


(k)      Foreign
Corrupt Practices. Neither the Company nor any subsidiary, nor to the knowledge of the Company or any subsidiary, any agent
or other person acting on behalf of the Company or any subsidiary, has: (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any
unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns
from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any subsidiary (or made by any person
acting on its behalf of which the Company is aware) which is in violation of law or (iv) violated in any material respect any
provision of the Foreign Corrupt Practices Act of 1977, as amended.


 


(l)      Neither
the Company, nor any subsidiary of the Company, nor, to the Company’s knowledge, any director, officer, agent, employee
or affiliate of the Company or any subsidiary of the Company, is a Person that is, or is owned or controlled by a Person that
is (i) on the list of Specially Designated Nationals and Blocked Persons maintained by U.S. Department of Treasury’s Office
of Office of Foreign Asset Control (“OFAC)” from time to time, (ii) the subject of any sanctions administered
or enforced by OFAC, the U.S. State Department, the United Nations Security Council, the European Union, Her Majesty’s Treasury,
or other relevant sanctions authority (collectively, “Sanctions”), (iii) has a place of business in, or is
operating, organized, resident or doing business in a country or territory that is, or whose government is, the subject of OFAC
economic sanction program (including without limitation Crimea, Cuba, Iran, North Korea, Sudan and Syria).


 






    	 	6	 



     

    

 


(m)      Except
with respect to the material terms and conditions of the transactions contemplated by this Agreement, all of which shall be publicly
disclosed by the Company as soon as possible after the date hereof, the Company covenants and agrees that neither it, nor any
other person acting on its behalf, will provide the Investor or its agents or counsel with any information that the Company believes
constitutes material non-public information, unless prior thereto the Investor shall have entered into a written agreement with
the Company regarding the confidentiality and use of such information. The Company understands and confirms that the Investor
shall be relying on the foregoing covenant in effecting transactions in securities of the Company.


 


4.     INDEMNIFICATION.
The Company will indemnify and hold the Investor and its directors, officers, shareholders, members, partners, employees and agents
(and any other persons with a functionally equivalent role of a person holding such titles notwithstanding a lack of such title
or any other title), each person who controls the Investor, and the directors, officers, shareholders, agents, members, partners
or employees (and any other persons with a functionally equivalent role of a person holding such titles notwithstanding a lack
of such title or any other title) of such controlling persons (each, a “Purchaser Party”) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts
paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation that any such Purchaser Party
may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements
made by the Company in this Agreement or the Note or (b) any action instituted against the Purchaser Parties in any capacity,
or any of them or their respective affiliates, by any stockholder of the Company who is not an affiliate of such Purchaser Party,
with respect to any of the transactions contemplated by herein (unless such action is based upon a breach of such Purchaser Party’s
representations, warranties or covenants under this Agreement or any agreements or understandings such Purchaser Party may have
with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such
Purchaser Party which constitutes fraud, gross negligence, willful misconduct or malfeasance). If any action shall be brought
against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall
promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its
own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel
in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of
such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action
there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company
and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses
of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for
any settlement by a Purchaser Party effected without the Company’s prior written consent, which shall not be unreasonably
withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any
Purchaser Party’s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party
in this Agreement or the Note. The indemnification required by this Section 4 shall be made by periodic payments of the amount
thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements
contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others
and any liabilities the Company may be subject to pursuant to law.


  






    	 	7	 



     

    

 


5.     COVENANTS
OF THE COMPANY.


 


(a)      Compliance
with Laws. The Company shall comply with all applicable laws, statutes, rules, regulations, orders, executive orders, directives,
policies, guidelines and codes having the force of law, whether local, national, or international, as amended from time to time,
including without limitation (i) all applicable laws that relate to money laundering, terrorist financing, financial record keeping
and reporting, (ii) all applicable laws that relate to anti-bribery, anti-corruption, books and records and internal controls,
including the United States Foreign Corrupt Practices Act of 1977, and (iii) any Sanctions laws and will not take any action which
will cause the Investor to be in violation of any such laws.


 


(b)      Use
of Proceeds. Neither the Company nor any Subsidiary will, directly or indirectly, use the proceeds of the issuance of the
Note hereunder or any proceeds from the sale of stock under the SEDA, or lend, contribute, facilitate or otherwise make available
such proceeds to any Person (i) to fund, either directly or indirectly, any activities or business of or with any Person that
is identified on the list of Specially Designated Nationals and Blocked Persons maintained by OFAC, or in any country or territory,
that, at the time of such funding, is, or whose government is, the subject of Sanctions or Sanctions programs, or (ii) in any
other manner that will result in a violation of Sanctions.


  


6.     GOVERNING
LAW. This Agreement shall be governed by and interpreted in accordance with the laws of the State of New York without regard
to the principles of conflict of laws. Each of the parties consents to the jurisdiction of the state courts of the State of New
York and the U.S. District Court for the District of New York sitting in Manhattan, for the adjudication of any civil action
asserted pursuant to this paragraph.


 






    	 	8	 



     

    

 


7.     NOTICES.
Any notices, consents, waivers or other communications required or permitted to be given under the terms hereof must be in writing
and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by electronic
mail (provided that the electronic mail transmission is returned in error or the sender is not otherwise notified of any error
in transmission); or (iii) one (1) Business Day after deposit with a nationally recognized overnight delivery service, in each
case properly addressed to the party to receive the same. The addresses and facsimile numbers for such communications shall be:


 


	If
    to the Company, to:	Omagine,
    Inc.
	 	136
Madison Avenue

        Suite
550

        New
        York, NY 10016

	 	 
	 	Attention:    Chief
    Executive Officer
	 	Telephone:  (212)
    563-4141
	 	Email:
Charles.Kuczynski@omagine.com

        Email:
        Frank.Drohan@omagine.com

	 	 
	With
    a copy to: 	Sichenzia
    Ross Friedman Ference LLP
	 	61
    Broadway
	 	New
    York, New York 10006
	 	Attention:  Michael
    Ference
	 	Telephone:
    (212) 930-9700
	 	Email:
       MFerence@srff.com


 


	If
    to the Holder:	YA
    II PN, Ltd. (f/k/a YA Global Master SPV, Ltd.)
	 	1012
    Springfield Avenue
	 	Mountainside,
    NJ  07092
	 	Attention:Mark
    Angelo
	 	Telephone:(201)
985-8300

        Email:
        MAngelo@yorkvilleadvisors.com

	 	 
	With
    a copy to:	David
    Gonzalez, Esq. 
	 	1012
    Springfield Avenue
	 	Mountainside,
    NJ  07092
	 	Telephone:(201)
    985-8300
	 	Email:  dgonzalez@yorkvilleadvisors.com
    


 


or
at such other address and/or electronic mail address and/or to the attention of such other person as the recipient party has specified
by written notice given to each other party three Business Days prior to the effectiveness of such change. Written confirmation
of receipt (i) given by the recipient of such notice, consent, waiver or other communication, or (ii) provided by a nationally
recognized overnight delivery service, shall be rebuttable evidence of personal service, or receipt from a nationally recognized
overnight delivery service in accordance with clause (i) or (ii) above, respectively.


 



    	 	9	 



     

    

 


8.      MISCELLANEOUS.


 


(a)      Counterparts.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party.


 


(b)      Assignment.
This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company
may not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Investor (other
than by merger). The Investor may assign any or all of its rights under this Agreement to any person to whom such Investor assigns
or transfers the Note, or a portion thereof, provided that such transferee agrees in writing to be bound, with respect to the
Note, by the provisions of the this Agreement that apply to the Investor.


 


(c)      Entire
Agreement; Amendments. This Agreement supersedes all other prior oral or written agreements between the Investor and the Company
with respect to the matters discussed herein, and this Agreement, and the instruments referenced herein, contain the entire understanding
of the parties with respect to the matters covered herein and therein and, except as specifically set forth herein or therein,
neither the Company nor the Investor makes any representation, warranty, covenant or undertaking with respect to such matters.
No provision of this Agreement may be waived or amended other than by an instrument in writing signed by the party to be charged
with enforcement.


 


[signature
page follows]


 




    	 	10	 



     

    

 


 


IN
WITNESS WHEREOF, each of the Investor and the Company have caused their respective signature page to this Note Purchase
Agreement to be duly executed as of the date first written above.


 


	 	COMPANY:
	 	 
	 	OMAGINE,
    INC.
	 	 	 
	 	By: 	/s/ Charles
    P. Kuczynski
	 	 	Charles
    P. Kuczynski
	 	 	Vice-President
    & Secretary
	 	 	 
	 	INVESTOR: 
	 	 
	 	YA
    II PN, LTD. 
	 	 	 
	 	By:	Yorkville
    Advisors Global LP
	 	Its:	Investment
    Manager
	 	 	 
	 	 	By:      Yorkville
    Advisors Global LLC
	

                                                                                 
	 	Its:      General
                                         Partner 

	 	 	
			
	 	By:	/s/ Gerald
    Eicke
	 	Name:	Gerald
    Eicke
	 	Title:	Managing
    Member




  



    	 	11	 



     

    




 


Exhibit
A

Form of Note